Back to search
FDAFDA · Food and drugs·Recall number Z-0549-2020

Boston Advanix Pancreatic Stent, Straight Leading Barb, 10F x 4cm UPN: M00536620

Published December 4, 2019 · Recall initiated: October 21, 2019

Summary

FDA records medical device Class II recall Z-0549-2020, published December 4, 2019 and initiated October 21, 2019. Recalling firm: Boston Scientific Corporation; Status: Terminated; Reported quantity: 66 units; Lot: Lot Numbers: 21776487 22136470 22896244 23902871. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Product manufactured between September 29, 2017 and September 12, 2019 have been labeled with a 36-month shelf life rather than the approved 18-month shelf life

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Boston Scientific Corporation
Distributor
Nationwide Foreign: Austria Australia Belgium Bulgaria Croatia Czech Rep Denmark Finland France Germany Great Britain Italy Japan Pakistan Poland Russian Fed. Slovakia South Africa Spain Sweden Switzerland Thailand Turkey
Lot
Lot Numbers: 21776487 22136470 22896244 23902871
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Boston Advanix Pancreatic Stent, Straight Leading Barb, 10F x 4cm UPN: M00536620 recalled?

Yes. FDA published recall Z-0549-2020 on December 4, 2019. Reported hazard: Product manufactured between September 29, 2017 and September 12, 2019 have been labeled with a 36-month shelf life rather than the approved 18-month shelf life

What should I do if I have this product?

Voluntary: Firm initiated · Letter